glp 1 side effects joint pain Your guide to GLP-1 Long-Term Effects Of GLP-1 Medications:
Description
Eli Lillys GLP-1 offering, tirzepatide, launched shortly after (as Mounjaro for T2D in 2022 and Zepbound for obesity in 2023), demonstrated greater HbA1c reduction and up to a 20% placebo-adjusted weight loss
& Magdy, Y
Considering that OSAS patients often present with multiple comorbiditiessuch as hypertension, coronary artery disease, and diabetesfurther large-scale, long-term follow-up studies are needed to clarify tirzepatides safety in multimorbid populations (63, 64)
In comparison, there was no difference between 5mg of tirzepatide and 2mg of semaglutide (Wegovy)
Vidal, J., Flores, L., Jimnez, A., Pan, A
